Ondine Biomedical (OBI) Stock Chart & Stock Price History C$13.50 -0.25 (-1.82%) As of 10:04 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesBuy This Stock Ondine Biomedical Stock Price Performance The Ondine Biomedical (OBI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 107.69%, with a year-to-date return of 42.11%. In the past month, the stock has decreased 12.90%, reflecting recent market activity. As of the latest close, Ondine Biomedical traded at C$13.75 with a market cap of C$7.13 billion and volume of 27,335 shares. Receive OBI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ondine Biomedical and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-4.66%1 Month Performance-12.90%3 Month Performance-1.82%Year-To-Date Performance+42.11%1 Year Performance+107.69% OBI Stock Chart for Friday, October, 10, 2025 OBI Chart by TradingView Ondine Biomedical Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/09/2025C$13.75C$13.75C$14.90C$13.5027,335 shsC$7.13 billion10/08/2025C$13.75C$13.75C$14.00C$13.6040,682 shsC$7.13 billion10/07/2025C$13.75C$13.75C$14.00C$13.5082,306 shsC$7.13 billion10/06/2025C$14.16C$13.75-2.90%C$14.20C$13.50231,462 shsC$7.13 billion10/03/2025C$14.25C$14.16-0.63%C$14.44C$13.50654,917 shsC$7.33 billion10/02/2025C$14.50C$14.25-1.72%C$14.73C$14.00122,896 shsC$7.38 billion10/01/2025C$14.50C$14.50C$15.00C$14.00151,882 shsC$7.50 billion09/30/2025C$14.50C$14.50C$15.00C$14.00136,421 shsC$7.50 billion09/29/2025C$14.25C$14.50+1.79%C$14.79C$14.0096,568 shsC$7.50 billion09/26/2025C$14.50C$14.25-1.76%C$15.00C$14.00390,189 shsC$7.37 billion Get the Latest News and Ratings for OBI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ondine Biomedical and its competitors with MarketBeat's FREE daily newsletter. 09/25/2025C$14.50C$14.50C$15.00C$14.00995,354 shsC$7.50 billion09/24/2025C$15.00C$14.50-3.33%C$15.07C$14.11468,718 shsC$7.50 billion09/23/2025C$15.00C$15.00C$15.50C$14.50271,481 shsC$7.76 billion09/22/2025C$15.00C$15.00C$15.50C$14.502,991 shsC$7.76 billion09/19/2025C$15.50C$15.00-3.23%C$16.00C$14.70133,219 shsC$7.76 billion09/18/2025C$15.00C$15.50+3.33%C$15.50C$15.00135,777 shsC$8.02 billion09/17/2025C$14.75C$15.00+1.69%C$15.50C$14.60152,955 shsC$7.76 billion09/16/2025C$15.30C$14.75-3.59%C$15.50C$14.6349,091 shsC$7.63 billion09/15/2025C$15.00C$15.30+2.00%C$16.00C$14.99986,708 shsC$7.92 billion09/12/2025C$15.50C$15.00-3.23%C$15.70C$15.00283,292 shsC$7.76 billion09/11/2025C$15.50C$15.50C$16.00C$15.11107,519 shsC$8.02 billion09/10/2025C$15.25C$15.50+1.64%C$15.80C$15.00188,798 shsC$8.02 billion09/09/2025C$15.25C$15.25C$15.50C$15.10609,893 shsC$7.89 billion Related Companies Genus Stock Chart Oxford Nanopore Technologies Stock Chart Oxford Biomedica Stock Chart PureTech Health Stock Chart Avacta Group Stock Chart Faron Pharmaceuticals Oy Stock Chart Bioventix Stock Chart 4basebio Stock Chart Scancell Stock Chart ImmuPharma Stock Chart Receive OBI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ondine Biomedical and its competitors with MarketBeat's FREE daily newsletter. This page (LON:OBI) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredTrump to get REVENGE on the banks??Rumors are swirling that Trump could target the banking system by upending the $5 trillion-a-day SWIFT network...The Oxford Club | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ondine Biomedical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ondine Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
